Skip to main content
          Skip to FDA Search
          Skip to in this section menu
          Skip to footer links


U.S. flagAn official website of the United States government

					Here’s how you know
          			Dot gov**The .gov means it’s official.**Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
							      SSL**The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. 
			U.S. Food and Drug Administration
				
        Search
            Menu
							
						Search FDA
									
									Submit search 
		Featured
							Contact FDA
	                FDA Guidance Documents
	                Recalls, Market Withdrawals and Safety Alerts
	                Press Announcements
	                Warning Letters
	                Advisory Committees
	                En Español

					Products
            Food
							Drugs
							Medical Devices
							Radiation-Emitting Products
							Vaccines, Blood, and Biologics
							Animal and Veterinary
							Cosmetics
							Tobacco ProductsTopics
            About FDA
							Combination Products
							Regulatory Information
							Safety
							Emergency Preparedness
							International Programs
							News and Events
							Training and Continuing Education
							Inspections and Compliance
							Science and ResearchInformation For
            Consumers
	            Patients
	            Industry
	            Health Professionals
	            Federal, State and Local Officials 
 In this section:

                FDA’s Labeling Resources for Human Prescription Drugs

FDA’s Labeling Resources for Human Prescription Drugs

                        Prescribing Information Resources
          Patient Labeling Resources
          Carton and Container Labeling Resources
          Selection of Appropriate SPL Codes for Human Prescription Drug Labeling
          Generic Drugs - Specific Labeling Resources
          Biological Products - Specific Labeling Resources
          Frequently Asked Questions about Labeling for Prescription Medicines
          Prescription Drug Labeling Contact Information Home
          Drugs
          Guidance, Compliance, & Regulatory Information
          Laws, Acts, and Rules
          FDA’s Labeling Resources for Human Prescription Drugs
          Biological Products - Specific Labeling ResourcesFDA’s Labeling Resources for Human Prescription Drugs Biological Products - Specific Labeling Resources
  
  					For Industry
	
    Share
    Post
    Linkedin

    Email
    PrintBiological products, including biosimilar and interchangeable biosimilars, are large and generally complex molecules.  A biological product may weigh more than 800 times than a drug product (e.g., aspirin).  See the figure below.

Biological product
On this page

Who is the audience for this webpage?
	Biosimilar and Interchangeable Biosimilar Guidances
	Deemed BLAs Guidance
	Nonproprietary Nomenclature of Biological Products Guidances and MAPP
	Other Biological Product-Specific Labeling Resources
	Contact Information


Who is the audience for this webpage?

FDA’s biological product-specific labeling resources on this webpage are primarily directed to industry staff who develop prescription labeling for biological products. For additional prescription drug labeling resources for industry such as those for the Prescribing Information, FDA-approved patient labeling, carton and container labeling, generic drug labeling, labeling databases, and product databases visit FDA’s Labeling Resources for Human Prescription Drugs. If you are a healthcare professional, patient, or caregiver, visit Frequently Asked Questions about Labeling for Prescription Medicines.

Biosimilar and Interchangeable Biosimilar Labeling Guidances

Biosimilarity and Interchangeability: Additional Draft Q&As on Biosimilar Development and the BPCI Act (Revision 1) (draft guidance)
	Biosimilars and Interchangeable Biosimilars: Licensure for Fewer Than All Conditions of Use for Which the Reference Product Has Been Licensed (draft guidance)
	Labeling for Biosimilar and Interchangeable Biosimilar Products (draft guidance)Deemed BLAs Guidance

The “Deemed to be a License” Provision of the BPCI Act - Questions and Answers (final guidance)Nonproprietary Nomenclature of Biological Products Guidances and MAPP

Nonproprietary Naming of Biological Products (final guidance – January 2017)
	Nonproprietary Naming of Biological Products: Update (draft guidance – March 2019)
	Procedures for Handling Requests for Nonproprietary Name Suffix Review for Biological Products Newly Licensed Under Section 351 of the PHS Act MAPPOther Biological Product-Specific Labeling Resources

Biosimilar Product Information: Includes a list and information about all FDA-licensed biosimilar products in the U.S.
	Biosimilars: Labeling, Scientific, Regulatory, and Clinical Considerations for Health Care Providers (June 2023 presentation)
	Classification Categories for Certain Supplements Under BsUFA III (draft guidance)
	Deemed BLA Database includes a list of applications for biological products under section 505 of the Federal Food, Drug, and Cosmetic Act was deemed to be a license for the biological product under section 351 of the Public Health Service Act.
	Labeling for Biological Products (December 2019 presentation and video) and (June 2019 presentation)
	Purple Book is a searchable online database that contains information about biological products licensed by the FDA under the Public Health Service Act including therapeutic biological products, vaccines, allergenic products, blood products, cellular and gene therapy products, and plasma derivatives.Contact Information

For specific application or supplement questions or for general questions about prescription drug labeling, please visit Prescription Drug Labeling Contact Information.

                                                                                  Content current as of:
      10/03/2023
              
              
Regulated Product(s)
		 DrugsFDA’s Labeling Resources for Human Prescription Drugs

          
                        Prescribing Information Resources
          Patient Labeling Resources
          Carton and Container Labeling Resources
          Selection of Appropriate SPL Codes for Human Prescription Drug Labeling
          Generic Drugs - Specific Labeling Resources
          Biological Products - Specific Labeling Resources
          Frequently Asked Questions about Labeling for Prescription Medicines
          Prescription Drug Labeling Contact Information
 
 Footer Links
    FDA Archive
          About FDA
          Accessibility
      Visitor Information
          Website Policies / Privacy
          No FEAR Act
          Vulnerability Disclosure Policy
      FOIA
          HHS.gov
          USA.gov
    Contact FDA
      Follow FDA on Facebook
      Follow FDA on X
      Follow FDA on Instagram
      Follow FDA on LinkedIn
      View FDA videos on YouTube
      Subscribe to FDA RSS feeds
    FDA Homepage
    Contact Number
      1-888-INFO-FDA (1-888-463-6332) Back toTop